Annual EBITDA
-$35.53 M
+$3.15 M+8.15%
31 December 2022
Summary:
Better Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$35.53 million, with the most recent change of +$3.15 million (+8.15%) on 31 December 2022. During the last 3 years, it has fallen by -$29.47 million (-486.45%). BTTX annual EBITDA is now -523.28% below its all-time high of -$5.70 million, reached on 31 December 2019.BTTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$4.50 M
+$1.73 M+27.75%
30 September 2023
Summary:
Better Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$4.50 million, with the most recent change of +$1.73 million (+27.75%) on 30 September 2023. BTTX quarterly EBITDA is now -343.35% below its all-time high of -$1.01 million, reached on 30 June 2020.BTTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$26.50 M
+$5.80 M+17.96%
30 September 2023
Summary:
Better Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$26.50 million, with the most recent change of +$5.80 million (+17.96%) on 30 September 2023. BTTX TTM EBITDA is now -2510.74% below its all-time high of -$1.01 million, reached on 30 June 2020.BTTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTTX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -486.4% | +62.3% | -3.8% |
| 5 y5 years | - | - | - |
BTTX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -486.4% | +8.2% | at high | +65.8% | -3.8% | +38.0% |
| 5 y | 5 years | -523.3% | +8.2% | -343.4% | +65.8% | -2510.7% | +38.0% |
| alltime | all time | -523.3% | +8.2% | -343.4% | +65.8% | -2510.7% | +38.0% |
Better Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$4.50 M(-27.7%) | -$26.50 M(-18.0%) |
| June 2023 | - | -$6.23 M(-23.8%) | -$32.30 M(-7.8%) |
| Mar 2023 | - | -$8.17 M(+7.5%) | -$35.02 M(-1.4%) |
| Dec 2022 | -$35.53 M(-8.1%) | -$7.60 M(-26.2%) | -$35.53 M(-13.5%) |
| Sept 2022 | - | -$10.30 M(+15.1%) | -$41.10 M(-3.8%) |
| June 2022 | - | -$8.95 M(+3.1%) | -$42.73 M(+2.0%) |
| Mar 2022 | - | -$8.68 M(-34.0%) | -$41.90 M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$38.68 M(+538.5%) | -$13.16 M(+10.3%) | -$38.68 M(+51.6%) |
| Sept 2021 | - | -$11.94 M(+46.9%) | -$25.52 M(+87.9%) |
| June 2021 | - | -$8.12 M(+48.7%) | -$13.59 M(+109.7%) |
| Mar 2021 | - | -$5.46 M(+438.2%) | -$6.48 M(+538.2%) |
| Dec 2020 | -$6.06 M(+6.3%) | - | - |
| June 2020 | - | -$1.01 M | -$1.01 M |
| Dec 2019 | -$5.70 M | - | - |
FAQ
- What is Better Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Better Therapeutics?
- What is Better Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Better Therapeutics?
- What is Better Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Better Therapeutics?
What is Better Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BTTX is -$35.53 M
What is the all time high annual EBITDA for Better Therapeutics?
Better Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$5.70 M
What is Better Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BTTX is -$4.50 M
What is the all time high quarterly EBITDA for Better Therapeutics?
Better Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.01 M
What is Better Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BTTX is -$26.50 M
What is the all time high TTM EBITDA for Better Therapeutics?
Better Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.01 M